only about 15,000 tonnes of mineral concentrate will be delivered to the hydrometallurgical plant .....
this from page 7 of the Section 38 Referral - Supporting Information Document
An on-site beneficiation plant would treat up to 750,000 tonne per annum (tpa) of ore to produce approximately 15,000 tpa of mineral concentrate. The beneficiation process would involve crushing, grinding, magnetic separation and flotation of the xenotime ore. The concentrate produced by the beneficiation plant would then be further processed via a hydrometallurgical process to produce up to 4,000 tpa of high purity mixed rare earth oxide for export overseas.
source:-
https://www.google.com.au/url?sa=t&rct=j&q=&esrc=s&source=web&cd=5&cad=rja&ved=0CD8QFjAE&url=https%3A%2F%2Fconsultation.epa.wa.gov.au%2Fseven-day-comment-on-referrals%2F13-184379%2Fsupporting_documents%2FSupporting%2520Information%2520Document.pdf&ei=76bjUpr8CK2kigepnYDACA&usg=AFQjCNHelM77mbwugJps2DqiwDptJHlPbQ
- Forums
- ASX - By Stock
- NTU
- knock-out criteria for ree stocks
knock-out criteria for ree stocks, page-7
-
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NTU (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $200.9M |
Open | High | Low | Value | Volume |
3.4¢ | 3.5¢ | 3.4¢ | $99.95K | 2.937M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 554507 | 3.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.5¢ | 470727 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 554507 | 0.034 |
8 | 599111 | 0.033 |
11 | 1618439 | 0.032 |
6 | 1870000 | 0.031 |
23 | 5718069 | 0.030 |
Price($) | Vol. | No. |
---|---|---|
0.035 | 452199 | 4 |
0.036 | 1825781 | 4 |
0.037 | 682494 | 7 |
0.038 | 1026316 | 2 |
0.039 | 50000 | 1 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
NTU (ASX) Chart |